{
  "id": 6251860,
  "title": "Eager capital prompts IPO plans for more Chinese makers of brain-computer interfaces",
  "url": "https://urgent.news/2026/09/08/eager-capital-prompts-ipo-plans-for-more-chinese-makers-of-brain-6251860",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-08T07:13:34.000Z",
  "source": {
    "name": "SCMP Tech",
    "slug": "scmp-tech",
    "url": "https://www.scmp.com/business/china-business/article/3366744/eager-capital-prompts-ipo-plans-more-chinese-makers-brain-computer-interfaces"
  },
  "original_language": "en",
  "account": "Chinese brain-computer interface (BCI) companies are capitalizing on the sector's popularity as a new favorite among private investors, with several aiming to go public on Chinese stock exchanges. Arfysica Innovation, a Shanghai-based firm specializing in products for central nervous system injuries and cognitive disorders, has become the latest BCI hopeful to register for IPO coaching to list on the Shanghai Stock Exchange's Nasdaq-style Star Market. The company, founded in 2015 with 100 million yuan (US$15 million) in registered capital, is led by founder Wang Wei, who holds a 51% stake and serves as legal representative. Arfysica raised capital in February and January, with undisclosed amounts and 160 million yuan from investors, respectively.\n\nAnother BCI company, Neuracle Medical Technology, has also registered for an IPO, having secured China's first approval for an implantable BCI system to help spinal cord injury patients regain hand movement. The firm, which has raised 72 million yuan in five funding rounds, is led by Xu Honglai, a Tsinghua University biomedical engineering graduate.\n\nAt least two additional Chinese BCI companies are pursuing onshore IPOs, with BrainCo, a Hangzhou-based firm recognized for its global recognition in AI, robotics, and other frontier fields, recently filing for a Hong Kong IPO. BrainCo is partnered with Beijing's Capital Medical University to develop BCI products for depression screening. This year's crop of IPO candidates is noted for their innovation, strategic value, capital backing, and research-and-development spending, as per a Morgan Stanley report. Almost three-quarters of these companies are considered domestic leaders in innovation, despite many still lagging behind global frontrunners. In total, 106 companies listed on the Star Market between June last year and mid-July 2026, raising about 281 billion yuan.",
  "summary": "A handful of home-grown Chinese companies involved in brain computer interfaces (BCIs) are moving towards initial public offerings (IPOs) on onshore markets, taking advantage of the sector’s status as a new darling of private capital. The trend fits into a broad pattern of hi-tech firms flocking to list on the Shanghai Stock Exchange’s Nasdaq-style Star Market. Among the BCI hopefuls,…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "SCMP Business",
        "title": "Eager capital prompts IPO plans for more Chinese makers of brain-computer interfaces",
        "url": "https://urgent.news/2026/09/08/eager-capital-prompts-ipo-plans-for-more-chinese-makers-of-brain",
        "published": "2026-09-08T07:13:34.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}